The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market By The End Of 2030?

The endoscopic retrograde cholangiopancreatography (ercp) market has seen robust expansion in recent years. It is projected to increase from $1.86 billion in 2025 to $2.03 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. The historical growth of this market can be attributed to several factors, including the prevalence of gallstones, an aging global population, the escalating burden of gastrointestinal diseases, the expansion of hospital endoscopy departments, and the rise of imaging-guided procedures.

The market for endoscopic retrograde cholangiopancreatography (ercp) is projected to experience robust expansion over the coming years, anticipated to reach $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this growth during the projection period include advancements in endoscopic training, earlier detection of pancreatic conditions, an increase in therapeutic procedures, improvements in hospital infrastructure, and the rising demand for minimally invasive care. Key trends identified for the forecast period encompass a growing prevalence of biliary disorders, a greater utilization of therapeutic endoscopy, an uptick in minimally invasive gastrointestinal procedures, the proliferation of specialized endoscopy units, and an intensified emphasis on prompt diagnosis of pancreatic ailments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp

Which Market Drivers Are Supporting The Expansion Of The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

The rising occurrence of gastrointestinal ailments is anticipated to drive the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market in the future. These conditions encompass a wide array of disorders or illnesses impacting the gastrointestinal (GI) tract, comprising the mouth, esophagus, stomach, small intestine, large intestine (colon), rectum, and anus, alongside auxiliary organs such as the liver, gallbladder, and pancreas. The growing incidence of gastrointestinal conditions is linked to multiple factors, including shifts in diet, an aging demographic, antibiotic consumption, lifestyle choices, and environmental elements. ERCP offers a significant benefit in managing patients suffering from gastrointestinal conditions by providing a less invasive approach to identify and address problems within the bile and pancreatic ducts, including gallstones, constrictions, growths, or infections. For example, in January 2024, data from the American Cancer Society, a US-based non-profit body, indicated an estimated 26,890 new cases of stomach cancer in the United States, with approximately 10,880 fatalities projected from this specific cancer type. Consequently, the expanding occurrence of gastrointestinal ailments is propelling the development of the endoscopic retrograde cholangiopancreatography (ERCP) market.

Which Segment Classifications Shape The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

The endoscopic retrograde cholangiopancreatography (ercp) market covered in this report is segmented –

1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices

2) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin

3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes

2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps

3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes

4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems

Which Trends Are Shaping The Future Of The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

Leading companies active in the ERCP market are prioritizing the development of novel technologies, such as the cholangioscope direct visualisation system, to facilitate advanced, high-resolution direct visualization of the bile and pancreatic ducts. The cholangioscope direct visualization system functions as a medical device capable of providing advanced, high-resolution imaging of these ducts during ERCP procedures. For instance, in July 2024, Penlon Limited, a UK-based medical device company, unveiled the VedVision Cholangioscope Direct Visualisation System, an advanced medical device crafted for high-resolution, direct visualization of the bile and pancreatic ducts, which significantly enhances diagnosis and therapeutic intervention during ERCP procedures. This system includes a 2 mm accessory channel and a dedicated guidewire channel for reliable access, along with a comprehensive selection of accessories like biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.

Which Companies Are Expanding Their Footprint In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

Major companies operating in the endoscopic retrograde cholangiopancreatography (ercp) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

Read the full endoscopic retrograde cholangiopancreatography (ercp) market report here:

https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report

How Is The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Distributed Across Key Geographic Regions?

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ercp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20770&type=smp

Browse Through More Reports Similar to the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market 2026, By The Business Research Company

Endoscopic Ultrasound Global Market Report

https://www.thebusinessresearchcompany.com/report/endoscopic-ultrasound-global-market-report

Neuroendoscopy Global Market Report

https://www.thebusinessresearchcompany.com/report/neuroendoscopy-global-market-report

Robotic Endoscopy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/robotic-endoscopy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model